Journal of Nuclear Medicine
The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and ...
About Us | Journal of Nuclear Medicine
The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical and basic science investigations, continuing education articles, state-of-the-art reviews, employment opportunities, and updates on rapidly changing issues in ...
SNMMI Annual Meeting Abstracts | Journal of Nuclear Medicine
View or Listen to JNM Podcast; Visit JNM on Facebook; Join JNM on LinkedIn; Follow JNM on Twitter; Subscribe to our RSS feeds
Practical Guide for Interpreting and Reporting Cardiac PET …
Nov 1, 2021 · One of the most exciting and useful advances in nuclear cardiology is the opportunity to measure myocardial blood flow (MBF) routinely as part of myocardial perfusion imaging (MPI) with positron emission tomography (PET). Incorporating MBF into the MPI evaluation improves diagnosis and assessment of
Precision Oncology in Melanoma: Changing Practices
Dec 1, 2024 · Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis for metastatic melanoma was poor because of limited treatment options. However, after multiple landmark clinical trials displaying the efficacy of combined BRAF/MEK inhibition for BRAF -mutant ...
Intraarterial Administration of Peptide Receptor Radionuclide …
Dec 1, 2024 · Peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with advanced meningioma. Recently, intraarterial application of the radiolabeled somatostatin receptor agonists has been introduced as an alternative to standard intravenous administration. In this study, we assessed the safety and efficacy of intraarterial PRRT in patients with advanced, progressive meningioma.
The SNMMI Practice Guideline for Therapy of Thyroid Disease with …
Oct 1, 2012 · III. DEFINITIONS. See also the SNMMI Guideline for General Imaging. 131 I is a β-emitting radionuclide with a physical half-life of 8.1 d; a principal γ-ray of 364 keV; and a principal β-particle with a maximum energy of 0.61 MeV, an average energy of 0.192 MeV, and a mean range in tissue of 0.4 mm (1,2).Therapy means the oral administration of 131 I as sodium iodide to treat papillary and ...
Physiological and Normal Variations in FDG uptake: A pictorial …
May 1, 2017 · 980 Objectives: 18-F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) scan, now considered the cornerstone of oncologic imaging requires knowledge of the normal patterns and variations in FDG distribution in the whole body. We aim to evaluate organ wise spectrum of distribution patterns, intensities and variations in normal physiological FDG uptake routinely ...
Understanding the Standardized Uptake Value, Its Methods, and ...
Sep 1, 2004 · METHOD-INFLUENCING FACTORS. The SUV is subject to errors that can arise in various quantitative methods (6,7).A criticism of being casual about SUV methodology has been made (), citing several factors to consider.However, as part of addressing PET procedures in a broader sense, several consensus groups (9–13)—in discussing some of these factors—have made protocol suggestions.
Procedure Guideline for Lymphoscintigraphy and the Use of ...
Oct 1, 2002 · I. Purpose. The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of (1) lymphoscintigraphy for identifying sentinel lymph nodes for excisional biopsy in patients with melanoma and (2) the use of the intraoperative gamma probe in the operating room.